Literature DB >> 30428010

Predictive value of echocardiography in Type 2 diabetes.

Peter G Jørgensen1, Tor Biering-Sørensen1, Rasmus Mogelvang1, Thomas Fritz-Hansen1, Tina Vilsbøll2,3, Peter Rossing2,3, Magnus T Jensen1.   

Abstract

AIMS: Echocardiography is suggested in the diagnostic work-up of patients with Type 2 diabetes (T2D). We investigated which echocardiographic parameters that best predicted cardiovascular disease (CVD) and whether this was persistent in both genders in a large cohort of outpatients with T2D. METHODS AND
RESULTS: We performed comprehensive echocardiography in 933 patients with T2D followed at specialized out-patients clinics in Copenhagen, Denmark. Follow-up was performed using national registries and included admission with future CVD events and non-CVD death as competing risk. Median follow-up was 4.8 years and 138 CVD events occurred. In univariable and multivariable analyses, a wide range of structural, diastolic, and systolic measurements predicted CVD including mean E/e' [hazard ratio (HR) 1.06, 95% confidence interval: (1.03-1.10), P < 0.001, C-statistics 0.74 (0.70-0.78)] and global longitudinal strain (GLS) [1.10 (1.01-1.20), P = 0.03, C-statistics 0.73 (0.69-0.77)]. However, this was modified by gender. In men, mean E/e' remained the strongest predictor in multivariable analyses and performed best measured by highest C-statistics [HR 1.15, 95% confidence interval: (1.08-1.21), P < 0.001, C-statistics 0.75 (0.71-0.80)] whereas in women this was GLS [1.39 (1.14-1.70), P = 0.001, C-statistics 0.79 (0.70-0.87)]. These findings persisted when excluding patients with known heart disease and when regarding all-cause mortality as a competing risk.
CONCLUSION: A range of echocardiographic parameters predicted CVD in patients with Type 2 diabetes, however, in multivariable analyses, mean E/e' was the strongest predictor and had the highest model performance. Importantly, this study identifies a hitherto undescribed gender interaction as mean E/e' performed best in men, whereas in women this was GLS. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular disease; echocardiography; prospective study; type 2 diabetes

Year:  2019        PMID: 30428010     DOI: 10.1093/ehjci/jey164

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  9 in total

1.  Making sense of subclinical cardiac alterations in patients with diabetes.

Authors:  Manan Pareek; Michael Hecht Olsen
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

Review 2.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

3.  Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.

Authors:  Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2019-08-30       Impact factor: 9.951

Review 4.  Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.

Authors:  Lavanya Athithan; Gaurav S Gulsin; Gerald P McCann; Eylem Levelt
Journal:  World J Diabetes       Date:  2019-10-15

5.  MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.

Authors:  Jesper Jensen; Morten Schou; Caroline Kistorp; Jens Faber; Tine W Hansen; Magnus T Jensen; Henrik U Andersen; Peter Rossing; Tina Vilsbøll; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2020-10-16       Impact factor: 9.951

6.  Linking Kidney and Cardiovascular Complications in Diabetes-Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture.

Authors:  Peter Rossing; Frederik Persson; Marie Frimodt-Møller; Tine Willum Hansen
Journal:  Diabetes       Date:  2021-01       Impact factor: 9.461

Review 7.  Echocardiography, an Indispensable Tool for the Management of Diabetics, with or without Coronary Artery Disease, in Clinical Practice.

Authors:  Konstantinos Katogiannis; Dimitrios Vlastos; Foteini Kousathana; John Thymis; Aikaterini Kountouri; Emmanouil Korakas; Panagiotis Plotas; Konstantinos Papadopoulos; Ignatios Ikonomidis; Vaia Lambadiari
Journal:  Medicina (Kaunas)       Date:  2020-12-18       Impact factor: 2.430

8.  Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.

Authors:  Roopameera Thirumathyam; Erik Arne Richter; Jens Peter Goetze; Mogens Fenger; Gerrit Van Hall; Ulrik Dixen; Jens Juul Holst; Sten Madsbad; Niels Vejlstrup; Per Lav Madsen; Nils Bruun Jørgensen
Journal:  BMJ Open       Date:  2022-08-11       Impact factor: 3.006

9.  Changes in Cardiac Morphology and Function in Individuals With Diabetes Mellitus: The UK Biobank Cardiovascular Magnetic Resonance Substudy.

Authors:  Magnus T Jensen; Kenneth Fung; Nay Aung; Mihir M Sanghvi; Sucharitha Chadalavada; Jose M Paiva; Mohammed Y Khanji; Martina C de Knegt; Elena Lukaschuk; Aaron M Lee; Ahmet Barutcu; Edd Maclean; Valentina Carapella; Jackie Cooper; Alistair Young; Stefan K Piechnik; Stefan Neubauer; Steffen E Petersen
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-16       Impact factor: 7.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.